Lactose (India) Ltd | 146 Cr. | 103 | 247/84.3 | 21.1 | 36.5 | 0.00 % | 18.0 % | 15.5 % | 10.0 |
MPS Pharmaa Ltd | 5.24 Cr. | 2.74 | 4.33/2.71 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 40.3 Cr. | 54.3 | 94.9/44.5 | 13.6 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 27.4 Cr. | 18.7 | 29.0/13.1 | 27.9 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 68.5 Cr. | 91.0 | 155/79.0 | 11.1 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 39,457 Cr. | 1,398 | 1,831/985 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Gennex Laboratories Ltd | 275 Cr. | 12.1 | 29.0/11.2 | 14.7 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.53 Cr. | 13.5 | 27.1/9.25 | 131 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 327 Cr. | 693 | 956/635 | 17.4 | 277 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 91.4 Cr. | 20.9 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 762 Cr. | 259 | 449/145 | 21.6 | 98.6 | 0.48 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 5.45 Cr. | 26.0 | 36.5/22.8 | 109 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 8.69 Cr. | 3.49 | 12.3/2.11 | 96.6 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 404 Cr. | 416 | 477/112 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,911 Cr. | 1,359 | 1,584/991 | 65.6 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 120 Cr. | 1.29 | 2.72/1.03 | 25.5 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 51.7 Cr. | 21.5 | 23.8/6.40 | 62.3 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.0 Cr. | 10.8 | 24.6/10.0 | 47.6 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 236 Cr. | 661 | 999/366 | 8.68 | 570 | 0.30 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 30.6 Cr. | 30.6 | 45.0/26.1 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 23.8 Cr. | 52.0 | 88.7/36.0 | 48.5 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 8.70 Cr. | 3.48 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 19.5 Cr. | 130 | 154/55.1 | 48.7 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 13.5 Cr. | 24.6 | 28.9/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 42.2 Cr. | 56.0 | 124/50.0 | 26.7 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 4.88 Cr. | 16.2 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 12,588 Cr. | 726 | 969/347 | 53.6 | 53.3 | 0.14 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 94.5 Cr. | 21.9 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 8.87 Cr. | 17.5 | 46.0/17.4 | 111 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 155 Cr. | 269 | 418/245 | 15.9 | 110 | 1.67 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 23.9 Cr. | 40.6 | 62.6/14.8 | 68.3 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 68,227 Cr. | 1,164 | 1,593/994 | 19.2 | 527 | 0.39 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 149 Cr. | 238 | 298/156 | 42.7 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 812 Cr. | 162 | 258/148 | 16.2 | 60.5 | 1.54 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 35.2 Cr. | 26.9 | 62.8/21.0 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 9,506 Cr. | 1,161 | 1,322/504 | 59.9 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.22 Cr. | 0.79 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 270 Cr. | 35.2 | 77.7/34.1 | 19.0 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 7.65 Cr. | 13.1 | 26.0/9.40 | | 255 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 79.6 Cr. | 3.38 | 6.25/2.82 | 121 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 64,101 Cr. | 30,165 | 31,900/25,260 | 48.0 | 1,657 | 1.36 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,938 Cr. | 765 | 837/495 | 27.8 | 205 | 0.39 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 150 Cr. | 52.9 | 75.8/31.3 | 26.2 | 47.8 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,294 Cr. | 823 | 1,078/440 | | 57.7 | 0.12 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 19,893 Cr. | 1,224 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 787 Cr. | 240 | 325/131 | 42.4 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 400 Cr. | 299 | 428/270 | 14.4 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 3,915 Cr. | 556 | 950/501 | 46.3 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,658 Cr. | 1,173 | 1,923/991 | 24.2 | 735 | 0.85 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,06,308 Cr. | 3,141 | 3,591/2,570 | 57.1 | 222 | 0.89 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,123 Cr. | 122 | 317/115 | 24.3 | 44.8 | 0.41 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,419 Cr. | 15.1 | 27.9/11.0 | 37.2 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,437 Cr. | 1,078 | 1,360/597 | 98.3 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 3,106 Cr. | 142 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,18,636 Cr. | 1,745 | 1,960/1,377 | 35.5 | 288 | 0.77 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 1,815 Cr. | 503 | 886/367 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,110 Cr. | 238 | 398/175 | 33.1 | 70.6 | 0.17 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 382 Cr. | 1,262 | 1,750/626 | 18.1 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,248 Cr. | 639 | 960/418 | 73.8 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 4,033 Cr. | 161 | 241/91.8 | 268 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 13,416 Cr. | 5,826 | 7,600/4,146 | 30.3 | 374 | 2.01 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,362 Cr. | 2,033 | 2,977/1,381 | 28.4 | 321 | 0.79 % | 33.3 % | 26.1 % | 8.00 |
Procter & Gamble Health Ltd | 8,365 Cr. | 5,040 | 5,850/4,641 | 34.1 | 368 | 1.59 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 226 Cr. | 64.1 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 19,442 Cr. | 4,250 | 6,453/3,701 | 31.6 | 820 | 0.82 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 120 Cr. | 97.8 | 348/81.0 | 9.01 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,996 Cr. | 489 | 582/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,935 Cr. | 776 | 1,998/670 | 35.7 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 15,946 Cr. | 12,429 | 18,100/5,540 | 66.4 | 1,087 | 0.11 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 460 Cr. | 20.5 | 56.5/20.0 | 27.1 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 14,501 Cr. | 810 | 1,639/660 | 7.78 | 399 | 1.17 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 3,088 Cr. | 56.4 | 101/41.7 | 24.5 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 10,252 Cr. | 226 | 359/130 | 27.9 | 50.3 | 0.27 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 114 Cr. | 72.1 | 145/70.1 | 11.1 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 383 Cr. | 107 | 177/90.2 | 93.5 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 93,031 Cr. | 2,037 | 2,403/1,493 | 32.4 | 343 | 0.39 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,116 Cr. | 557 | 980/498 | 12.5 | 319 | 0.32 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 31,751 Cr. | 589 | 661/385 | 83.5 | 84.6 | 0.20 % | 10.4 % | 8.67 % | 2.00 |
Kwality Pharmaceuticals Ltd | 745 Cr. | 718 | 1,070/481 | 21.2 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 156 Cr. | 72.6 | 129/60.3 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 860 Cr. | 178 | 370/155 | 18.1 | 103 | 1.68 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 583 Cr. | 363 | 431/271 | 32.6 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 13,825 Cr. | 868 | 1,310/617 | 41.5 | 373 | 0.58 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 23,735 Cr. | 1,525 | 2,030/1,303 | 37.1 | 207 | 0.80 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,357 Cr. | 204 | 328/109 | 34.1 | 36.1 | 0.98 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 34,549 Cr. | 1,362 | 1,758/1,052 | 47.1 | 264 | 0.29 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,826 Cr. | 62.2 | 108/57.5 | 18.7 | 56.5 | 1.61 % | 12.3 % | 8.68 % | 2.00 |
Ind-Swift Ltd | 67.8 Cr. | 12.5 | 34.7/12.0 | 1.05 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 426 Cr. | 70.3 | 186/67.2 | 5.15 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,225 Cr. | 241 | 388/190 | | 118 | 0.62 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 4,772 Cr. | 387 | 465/267 | 64.0 | 97.6 | 0.31 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,400 Cr. | 1,646 | 3,379/1,243 | 50.9 | 369 | 0.36 % | 9.62 % | 9.07 % | 10.0 |
Gufic BioSciences Ltd | 3,562 Cr. | 355 | 504/278 | 43.4 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 10,694 Cr. | 441 | 725/389 | 22.3 | 141 | 0.34 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 39,457 Cr. | 1,398 | 1,831/985 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,754 Cr. | 2,760 | 3,148/1,921 | 54.7 | 98.7 | 1.16 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 23,494 Cr. | 1,426 | 2,221/1,200 | 21.0 | 557 | 1.40 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,994 Cr. | 430 | 659/359 | 25.5 | 141 | 1.16 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 19,829 Cr. | 1,456 | 1,594/816 | 60.2 | 204 | 0.50 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 96,455 Cr. | 1,156 | 1,421/1,020 | 17.1 | 402 | 0.69 % | 23.1 % | 18.3 % | 1.00 |
Dishman Carbogen Amcis Ltd | 2,902 Cr. | 185 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,19,531 Cr. | 1,480 | 1,702/1,310 | 24.0 | 351 | 0.88 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,145 Cr. | 1,861 | 2,641/1,221 | 27.5 | 334 | 0.27 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 386 Cr. | 131 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,178 Cr. | 112 | 186/92.2 | 13.9 | 95.8 | 0.45 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 68.0 Cr. | 41.8 | 92.0/40.4 | 113 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 39,608 Cr. | 330 | 405/270 | 41.2 | 180 | 0.15 % | 6.13 % | 4.64 % | 5.00 |
Beta Drugs Ltd | 1,747 Cr. | 1,731 | 2,215/1,048 | 42.6 | 179 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 149 Cr. | 93.8 | 158/76.3 | 20.6 | 43.2 | 1.28 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 170 Cr. | 72.0 | 99.8/67.8 | 36.5 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 19,926 Cr. | 7,970 | 9,211/5,140 | 119 | 272 | 0.30 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,994 Cr. | 690 | 863/544 | 40.4 | 103 | 0.67 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 211 Cr. | 100 | 145/69.9 | 8.39 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 59,143 Cr. | 4,946 | 6,440/4,407 | 27.4 | 961 | 0.81 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 17,705 Cr. | 901 | 1,304/725 | 31.0 | 264 | 1.22 % | 13.1 % | 11.4 % | 2.00 |
Albert David Ltd | 460 Cr. | 805 | 1,754/763 | 11.4 | 724 | 1.43 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 31,701 Cr. | 2,538 | 3,486/2,022 | 34.4 | 290 | 1.42 % | 33.3 % | 25.6 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,143 Cr. | 281 | 571/258 | 22.0 | 120 | 1.82 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,849 Cr. | 419 | 635/312 | 24.5 | 136 | 0.24 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 17,967.14 Cr | 1,075.98 | | 41.84 | 185.78 | 0.34% | 15.91% | 16.73% | 6.19 |